Literature DB >> 7656342

Assessing the activity of rheumatoid arthritis.

M Boers1, P L van Riel, D T Felson, P Tugwell.   

Abstract

Disease activity in rheumatoid arthritis is not easily measured. The validity of current measures has been reviewed. Recent international efforts have resulted in consensus over a minimum (WHO/ILAR) core set of endpoints in RA trials: pain, patient and physician (assessor) global assessment, physical disability, swollen joint count, tender joint count, acute phase reactants; and for studies of one or more years' duration: radiographs of joints. The near future will hopefully see validation of new measures, also in terrains not currently covered by the core set.

Entities:  

Mesh：

Year:  1995        PMID： 7656342     DOI： 10.1016/s0950-3579(05)80192-x

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN： 0950-3579


  6 in total

1.  Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?

Authors:  Nasim Ahmed Khan; Horace Jack Spencer; Essam Ahmed Abda; Rieke Alten; Christof Pohl; Codrina Ancuta; Massimiliano Cazzato; Pál Géher; Laure Gossec; Dan Henrohn; Merete Lund Hetland; Nevsun Inanc; Johannes Wg Jacobs; Eduardo Kerzberg; Maria Majdan; Omondi Oyoo; Ruben A Peredo-Wende; Zahraa Ibrahim Selim; Fotini Nikolaos Skopouli; Alberto Sulli; Kim Hørslev-Petersen; Peter C Taylor; Tuulikki Sokka
Journal:  Ann Rheum Dis       Date:  2012-04-24       Impact factor: 19.103

2.  Applying low disease activity criteria using the DAS28 to assess stability in patients with rheumatoid arthritis.

Authors:  H J M Vrijhoef; J P M Diederiks; C Spreeuwenberg; Sj Van der Linden
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

3.  Discordance of global assessment by patients and physicians is higher in osteoarthritis than in rheumatoid arthritis: a cross-sectional study from routine care.

Authors:  Isabel Castrejon; Najia Shakoor; Jacquelin R Chua; Joel A Block
Journal:  Rheumatol Int       Date:  2018-10-06       Impact factor: 2.631

Review 4.  Chronic Pain in Patients with Rheumatoid Arthritis.

Authors:  Kristen Mathias; Abhimanyu Amarnani; Neha Pal; Jay Karri; Daniel Arkfeld; Jonathan M Hagedorn; Alaa Abd-Elsayed
Journal:  Curr Pain Headache Rep       Date:  2021-07-16

5.  Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication: a quantitative study.

Authors:  Jon Packham; Paul Arkell; Tom Sheeran; Ann Brownfield; Anthony Cadwgan; Sarah Ryan
Journal:  Clin Rheumatol       Date:  2017-05-19       Impact factor: 2.980

6.  Discordance between the patient's and physician's global assessment in rheumatoid arthritis: Data from the REAL study-Brazil.

Authors:  Maria Fernanda Brandão Resende Guimarães; Maria Raquel da Costa Pinto; Gustavo Gomes Resende; Carla Jorge Machado; Ana Beatriz Vargas-Santos; Rodrigo Balbino Chaves Amorim; Ana Paula Monteiro Gomides; Cleandro Pires de Albuquerque; Manoel Barros Bértolo; Paulo Louzada Júnior; Isabela Araújo Santos; Rina Dalva Neubarth Giorgi; Nathalia de Carvalho Saciloto; Sebastião Cezar Radominski; Fernanda Maria Borghi; Karina Rossi Bonfiglioli; Henrique Carriço da Silva; Maria de Fátima L da Cunha Sauma; Marcel Lobato Sauma; Júlia Brito de Medeiros; Ivânio Alves Pereira; Gláucio Ricardo Werner de Castro; Claiton Viegas Brenol; Ricardo Machado Xavier; Licia Maria Henrique Mota; Geraldo da Rocha Castelar-Pinheiro
Journal:  PLoS One       Date:  2020-03-13       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.